Latest Distributions News

Biome Australia Limited has delivered record sales revenue in Q4 FY25 alongside positive EBITDA, setting the stage for its first full-year net profit. Strategic product launches and international expansion underpin its strong growth trajectory.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Murray Cod Australia reports a near tripling of biomass and strong sales growth in Q4 FY25, while advancing key certifications and expanding market reach.

Buru Energy advances its Rafael Gas Project in Western Australia with a focus on sustainable growth, targeting a final investment decision in 2026 and production start in 2028. The project aims to supply local power generation with trucked LNG and condensate, replacing costly imports.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Victory Metals has produced a 94% total rare earth oxide product enriched in heavy rare earths from its North Stanmore project, marking a first for Australian clay-hosted deposits and setting a new industry benchmark.

NuEnergy Gas Limited reports a mixed quarter with ongoing exploration costs and a strategic push towards early gas sales, while actively seeking new funding to sustain operations.

Stealth Group Holdings reports a robust $6 million in pre-sales for iPhone 17 accessories, marking a 50% increase from last year and signaling strong momentum ahead of the global launch.

Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.